This page contains brief information about sacituzumab govitecan-hziy and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Sacituzumab govitecan-hziy is approved to treat:
- Breast cancer that is triple negative and has metastasized (spread to other parts of the body). It is used in adults who have received at least two therapies for metastatic disease.
This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that sacituzumab govitecan-hziy provides a clinical benefit in these patients.
Sacituzumab govitecan-hziy is also being studied in the treatment of other types of cancer.
More About Sacituzumab Govitecan-hziy
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Sacituzumab Govitecan-hziy - Check for trials from NCI's list of cancer clinical trials now accepting patients.